Piper Jaffray has issued a report on Allergan Inc.'s (NYSE:

) conference call on April 5th. According to the report, “The Piper Jaffray Specialty Pharmaceuticals team will host a conference call on Tuesday, April 5th at 12:45PM ET with Dr. Victor Nitti, a leading urologist with deep experience in treating patients with urinary tract disorders, including overactive bladder (OAB). Dr. Nitti is Vice-Chairman of Urology at NYU and has also been involved in studies evaluating Botox for neurogenic OAB (nOAB) and idiopathic OAB (iOAB).” AGN is rated Overweight and has an $81 Price Target. AGN closed Friday at $72.45 a share.